These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1193 related items for PubMed ID: 32884949

  • 1. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J, Du H, Shen M, Zhao Z, Ye X.
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [Abstract] [Full Text] [Related]

  • 2. [Diosgenin alleviates NAFLD induced by a high-fat diet in rats via mTOR/SREBP-1c/HSP60/MCAD/SCAD signaling pathway].
    Chen SW, Yin GL, Song CY, Meng DC, Yu WF, Zhang X, Feng YN, Liang PP, Zhang FX.
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5304-5314. PubMed ID: 38114120
    [Abstract] [Full Text] [Related]

  • 3. Study on the mechanism of Shenling Baizhu powder on the pathogenesis of pregnancy complicated with non-alcoholic fatty liver, based on PI3K/AKT/mTOR signal pathway.
    Le Y, Wang Z, Zhang Q, Miao L, Wang X, Han G.
    Eur J Histochem; 2024 Sep 17; 68(3):. PubMed ID: 39287141
    [Abstract] [Full Text] [Related]

  • 4. Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/mTOR pathway.
    Shi C, Xue W, Han B, Yang F, Yin Y, Hu C.
    Eur J Pharmacol; 2019 May 05; 850():15-22. PubMed ID: 30753863
    [Abstract] [Full Text] [Related]

  • 5. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways.
    You L, Wang T, Li W, Zhang J, Zheng C, Zheng Y, Li S, Shang Z, Lin J, Wang F, Qian Y, Zhou Z, Kong X, Gao Y, Sun X.
    J Ethnopharmacol; 2024 Jul 15; 329():118165. PubMed ID: 38588984
    [Abstract] [Full Text] [Related]

  • 6. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway.
    Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH.
    World J Gastroenterol; 2019 Dec 07; 25(45):6607-6618. PubMed ID: 31832001
    [Abstract] [Full Text] [Related]

  • 7. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR, Yang HJ, Park KI, Ma JY.
    Phytomedicine; 2019 Mar 01; 55():14-22. PubMed ID: 30668424
    [Abstract] [Full Text] [Related]

  • 8. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.
    Kim DE, Chang BY, Jeon BM, Baek JI, Kim SC, Kim SY.
    Int J Mol Sci; 2020 Jun 25; 21(12):. PubMed ID: 32630596
    [Abstract] [Full Text] [Related]

  • 9. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
    Zhu X, Bian H, Wang L, Sun X, Xu X, Yan H, Xia M, Chang X, Lu Y, Li Y, Xia P, Li X, Gao X.
    Free Radic Biol Med; 2019 Sep 25; 141():192-204. PubMed ID: 31226399
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Exploring the effect and mechanism of Hippophae rhamnoides L. triterpenoid acids on improving NAFLD based on network pharmacology and experimental validation in vivo and in vitro.
    Ren L, Wang R, Wang Y, Tie F, Dong Q, Wang H, Hu N.
    J Ethnopharmacol; 2024 Dec 05; 335():118657. PubMed ID: 39127115
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
    Hu J, Hong W, Yao KN, Zhu XH, Chen ZY, Ye L.
    World J Gastroenterol; 2019 Mar 28; 25(12):1492-1501. PubMed ID: 30948912
    [Abstract] [Full Text] [Related]

  • 15. [Effect of electroacupuncture at "Fenglong" (ST 40) on liver cholesterol metabolism in hyperlipidemia rats based on AMPK/mTOR pathway].
    Jin S, Liu J, Li D, Zhang X, Liu M, Zhang H, Pan X.
    Zhongguo Zhen Jiu; 2024 Oct 12; 44(10):1155-64. PubMed ID: 39401813
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dapagliflozin attenuates steatosis in livers of high-fat diet-induced mice and oleic acid-treated L02 cells via regulating AMPK/mTOR pathway.
    Luo J, Sun P, Wang Y, Chen Y, Niu Y, Ding Y, Xu N, Zhang Y, Xie W.
    Eur J Pharmacol; 2021 Sep 15; 907():174304. PubMed ID: 34224699
    [Abstract] [Full Text] [Related]

  • 18. Thymoquinone attenuates hepatic lipid accumulation by inducing autophagy via AMPK/mTOR/ULK1-dependent pathway in nonalcoholic fatty liver disease.
    Zhang D, Zhang Y, Wang Z, Lei L.
    Phytother Res; 2023 Mar 15; 37(3):781-797. PubMed ID: 36479746
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
    Wang Z, Li S, Wang R, Guo L, Xu D, Zhang T, Xu Y, Wang W, Wang M, Gan Z, Wang X.
    Mol Med; 2020 Jun 05; 26(1):54. PubMed ID: 32503411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.